F15.182
Other stimulant abuse with stimulant-induced sleep disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code F15.182 refers to a condition where an individual abuses stimulants—such as amphetamines, methamphetamines, or other related substances—and develops a sleep disorder directly caused by their stimulant use. This condition highlights the complex relationship between stimulant abuse and sleep health, emphasizing the importance of recognizing and managing these interconnected issues. It is a specific diagnosis used primarily by healthcare providers to identify and document this dual problem, which can significantly impact an individual's overall well-being and quality of life.
Causes & Symptoms
Clinical Causes: Use of illicit stimulants like methamphetamine, cocaine, or synthetic drugs Misuse or overuse of prescription stimulants prescribed for ADHD or other conditions Prolonged or high-dose intake of stimulants leading to dependence Concurrent use of multiple substances exacerbating stimulant effects Psychological factors such as stress or underlying mental health issues prompting stimulant use
Key Symptoms: Insomnia or difficulty falling asleep Frequent disruptions during sleep cycles Restlessness or an inability to relax at night Increased alertness or hyperactivity Irritability or agitation Elevated heart rate or blood pressure Decreased overall sleep duration Daytime fatigue and decreased concentration Anxiety or jitteriness
Diagnostic & Treatment
Diagnosis Path: Diagnosing stimulant abuse with sleep disorder involves a detailed clinical history, including substance use patterns and sleep habits. Healthcare providers may perform physical examinations, laboratory tests to detect stimulant metabolites, and sleep studies like polysomnography to assess sleep disturbances. The diagnosis is primarily based on the patient's self-reported substance use, clinical symptoms, and the exclusion of other sleep disorders.
Treatment Protocols: The management of this condition typically involves a multidisciplinary approach, focusing on both substance abuse treatment and sleep restoration. Interventions may include:
Clinical Advice & FAQs
Billing Guidance
Is F15.182 a billable ICD-10 code?
Yes, F15.182 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F15.182?
Clinical documentation must specify the nature of Other stimulant abuse with stimulant-induced sleep disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference